ERBB2 and breast carcinoma: HER2 overexpression, which is defined as an abnormal increase in the number of HER2 receptors on the surface of cancer cells, has been observed in a subset of head and neck squamous cell carcinomas, as well as in other types of cancer, such as breast cancer.